Clinical Trial Update: Basiliximab Treating Interstitial Pneumonia of CADM [Phase 2]

View source ↗

Summary

Phase 2 trial investigating basiliximab for interstitial pneumonia in clinically amyopathic dermatomyositis (CADM).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Interstitial Lung Disease

Drugs mentioned

• Basiliximab (Simulect) (Basiliximab)

Snippet

Sponsor: RenJi Hospital | Conditions: Lung; Disease, Interstitial, With Fibrosis, Dermatomyositis | Phase 2 | Status: UNKNOWN